The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis.
Journal Information
Full Title: Ital J Pediatr
Abbreviation: Ital J Pediatr
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding Not applicable."
Protocol Registration
Evidence found in paper:
"This systematic review was carried out and reported using the protocols of the preferred reporting items for systematic reviews and meta-analyses []. The protocol was registered on the International Prospective Register of Systematic Reviews (PROSPERO CRD42022375107)."
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025